US Stock Market Move | Sale of up to 20 million US dollars in common stock of GlucoTrack (GCTK.US) soars over 123%

On Friday, GlucoTrack (GCTK.US) soared over 123%, closing at $10.91. In terms of news, GlucoTrack announced on September 11, 2025, that they have entered into an agreement with Sixth District Capital to sell up to $20 million common shares. GlucoTrack's main business is developing implantable continuous blood glucose monitoring devices, which directly measure blood glucose levels, eliminating lag time, and are suitable for diabetes patients.